Suppr超能文献

大麻使用者的病前智商高于其他首发精神病患者。

Cannabis users have higher premorbid IQ than other patients with first onset psychosis.

机构信息

Institute of Psychiatry, Department of Psychosis Studies and Biomedical Research Centre, King's College, de Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom; Sezione di Psichiatria del Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche (BioNeC), Università di Palermo, Via "Gaetano La Loggia" 1, 90100 Palermo, Italy.

出版信息

Schizophr Res. 2013 Oct;150(1):129-35. doi: 10.1016/j.schres.2013.07.046. Epub 2013 Aug 17.

Abstract

BACKGROUND

A number of studies have reported that patients with psychosis who use cannabis have better cognitive performance than those who do not. This is surprising as cannabis can impair cognition in healthy subjects. An obvious question is whether the better current performance of psychotic patients who have used cannabis is a reflection of their having a higher premorbid IQ than those psychotic patients who haven't used cannabis.

AIM

In a sample of patients at their first episode of psychosis, we tested the hypothesis that patients who smoked cannabis would have a higher premorbid IQ than patients who did not.

METHODOLOGY

279 participants (119 patients and 160 healthy controls) were assessed in order to obtain current and premorbid IQ measures and detailed information on cannabis use. We examined the association between cannabis use and both premorbid and current IQ in patients and controls.

RESULTS

Patients who had ever smoked cannabis had significantly higher current (p<.001) and premorbid IQ (p=.004) compared to patients who had never used cannabis. This difference was not found among controls.

CONCLUSIONS

These findings suggest that the better cognitive performance of patients with their first episode of psychosis who have used cannabis compared with those who haven't is due to the better premorbid IQ of the former.

摘要

背景

许多研究报告称,患有精神病的使用大麻的患者的认知表现优于未使用大麻的患者。这令人惊讶,因为大麻会损害健康受试者的认知能力。一个明显的问题是,使用大麻的精神病患者当前表现更好,是否反映了他们的先天智商高于未使用大麻的精神病患者。

目的

在首次出现精神病的患者样本中,我们检验了这样一个假设,即吸食大麻的患者的先天智商高于未吸食大麻的患者。

方法

为了获得当前和先天智商的衡量标准以及关于大麻使用的详细信息,我们评估了 279 名参与者(119 名患者和 160 名健康对照者)。我们检查了大麻使用与患者和对照组的先天和当前智商之间的关联。

结果

与从未使用过大麻的患者相比,曾经吸食过大麻的患者的当前智商(p<.001)和先天智商(p=.004)均显著更高。在对照组中没有发现这种差异。

结论

这些发现表明,与从未使用过大麻的患者相比,首次出现精神病的使用过大麻的患者的认知表现更好,这是由于前者的先天智商更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验